Invention Grant
- Patent Title: Substituted xanthine derivatives
- Patent Title (中): 取代黄嘌呤衍生物
-
Application No.: US14391443Application Date: 2013-04-12
-
Publication No.: US09328113B2Publication Date: 2016-05-03
- Inventor: Roger D. Tung , Bhaumik Pandya , Scott L. Harbeson
- Applicant: Concert Pharmaceuticals, Inc.
- Applicant Address: US MA Lexington
- Assignee: Concert Pharmaceuticals, Inc.
- Current Assignee: Concert Pharmaceuticals, Inc.
- Current Assignee Address: US MA Lexington
- Agency: McCarter & English, LLP
- Agent Steven G. Davis; Emily Dertz
- International Application: PCT/US2013/036454 WO 20130412
- International Announcement: WO2013/155465 WO 20131017
- Main IPC: C07D473/10
- IPC: C07D473/10 ; C07D487/04
Abstract:
This invention relates to novel compounds that are substituted xanthine derivatives and pharmaceutically acceptable salts thereof. For example, this invention relates to novel substituted xanthine derivatives that are derivatives of pentifylline. This invention also provides compositions comprising one or more compounds of this invention and a carrier and the use of the disclosed compounds and compositions in methods of treating diseases and conditions for which pentifylline and related compounds are beneficial.
Public/Granted literature
- US20150119407A1 SUBSTITUTED XANTHINE DERIVATIVES Public/Granted day:2015-04-30
Information query
